MEDAREX
associated with 13 other trademarks
biochemicals; namely, monoclonal antibodies for in vitro or scientific research regarding acquired cancer, immune deficiency syndrome ("AIDS"), and ot...

Words that describe this trademark:

immune deficiency syndrome  research regarding  monoclonal antibodies  scientific research  cancer immune  biochemicals  acquired  regarding  vitro  antibodies 

Serial Number:

74169009

Mark:

MEDAREX

Status:

Cancelled-Section 8

Status Date:

03-27-2020

Filing Date:

Registration Number:

1944385

Registration Date:

12-26-1995

Goods and Services:

biochemicals; namely, monoclonal antibodies for in vitro or scientific research regarding acquired cancer, immune deficiency syndrome ("AIDS"), and other infectious diseases, autoimmune diseases, and cardiovascular diseases monoclonal antibody therapeutic pharmaceuticals for use in the treatment of cancer, acquired immune deficiency syndrome ("AIDS"), and other infectious diseases, autoimmune diseases, and cardiovascular diseases

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

11-29-1994

Mark Drawing Status:

Typed Drawing

Abandon Date:

N/A

Business Name:

BRISTOL-MYERS SQUIBB COMPANY

Correspondent Name:

Recent Trademark filings by this company